Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep;33(3):537-55.
doi: 10.1016/j.psc.2010.04.005.

Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators

Affiliations
Review

Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators

Ellen Driessen et al. Psychiatr Clin North Am. 2010 Sep.

Abstract

Cognitive behavioral therapy (CBT) is efficacious in the acute treatment of depression and may provide a viable alternative to antidepressant medication (ADM) for even more severely depressed unipolar patients when implemented in a competent fashion. CBT also may be of use as an adjunct to medication treatment of bipolar patients, although there have been few studies and they are not wholly consistent. CBT does seem to have an enduring effect that protects against subsequent relapse and recurrence following the end of active treatment, which is not the case for medications. Single studies that require replication suggest that patients who are married or unemployed or who have more antecedent life events may do better in CBT than in ADM, as might patients who are free from comorbid Axis II disorders, whereas patients with comorbid Axis II disorders seem to do better in ADM than in CBT. There also are indications that CBT may work through processes specified by theory to produce change in cognition that in turn mediate subsequent change in depression and freedom from relapse following treatment termination, although evidence in that regard is not yet conclusive.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436–1442. - PubMed
    1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289(23):3095–3105. - PubMed
    1. Keller MB. Long-term treatment of recurrent and chronic depression. J Clin Psychiatry. 2001;62 suppl 24:3–5. - PubMed
    1. Rush AJ, Fava M, Wisniewski SR, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25(1):119–142. - PubMed
    1. DeRubeis RJ, Young PR, Dahlsgaard KK. Affective Disorders. In: Bellack AS, Hersen M, editors. Comprehensive clinical psychology. vol. 6. Oxford: Pergamon; 1998. pp. 339–366.

Publication types

MeSH terms

Substances